Clinical Trials Browser

Phase 3 × INDUSTRY × Neurofibromatosis 1 × Clear all

NCT04924608 2026-01-12

KOMET

Phase 3 Active not recruiting

145 enrolled 17 charts 1 FDA

Neurofibromatosis 1, Neurofibroma, Plexiform

NCT05913037 2025-03-06

FCN-159 in Adult Patients With Symptomatic, Inoperable Neurofibromatosis Type 1-Related Plexiform Neurofibromas

Phase 3 Active not recruiting

Neurofibromatosis 1, Neurofibroma, Plexiform